Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis.

Jung, Jongheon; Kim, Hyae Young; Kim, Dong-Gil; Park, Seog Yun; Ko, A Ra; Han, Ji-Youn; Kim, Heung Tae; Lee, Jin Soo; Lee, Youngjoo

Jung, Jongheon; Kim, Hyae Young; Kim, Dong-Gil; Park, Seog Yun; Ko, A Ra; Han, Ji-Youn; Kim, Heung Tae; Lee, Jin Soo; Lee, Youngjoo.

Afiliação

Jung J; Department of Internal Medicine, National Cancer Center, Goyang, Korea.
Kim HY; Department of Radiology, National Cancer Center, Goyang, Korea.
Kim DG; Department of Internal Medicine, National Cancer Center, Goyang, Korea.
Park SY; Department of Pathology, National Cancer Center, Goyang, Korea.
Ko AR; Department of Internal Medicine, National Cancer Center, Goyang, Korea.
Han JY; Department of Internal Medicine, National Cancer Center, Goyang, Korea.
Kim HT; Department of Internal Medicine, National Cancer Center, Goyang, Korea.
Lee JS; Department of Internal Medicine, National Cancer Center, Goyang, Korea.
Lee Y; Department of Internal Medicine, National Cancer Center, Goyang, Korea.

Cancer Res Treat ; 53(1): 77-86, 2021 Jan.

Article em En | MEDLINE | ID: mdl-32777877

Assuntos

Inibidores de Checkpoint Imunológico/efeitos adversos; Pneumonia/induzido quimicamente; Idoso; Feminino; Humanos; Inibidores de Checkpoint Imunológico/farmacologia; Masculino; Estudos Retrospectivos

Palavras-chave

Immune checkpoint inhibitor; Lung neoplasms; Pneumonia; Sequential targeted agent

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google